Table 1.
Drug type | Target effect | Disease condition | Effective | Reference | |
---|---|---|---|---|---|
Antimicrobials | Penicillin’s, Cephalosporin’s Vancomycin | peptidoglycan biosynthesis – cell wall inhibition | IBD | No | Alcedo et al., 2016 Dubuisson et al., 2010 |
Clarithromycin Azithromycin | macrolide protein synthesis inhibitors | IBD | Yes | ||
Ethambutol | cell metabolism | IBD | Yes | ||
Rifamycin | inhibits RNA synthesis | IBD | Yes | ||
Antimicrobials | Ciprofloxacin Fluoroquinolone | inhibition of DNA gyrase | CD | Varied results | Lal and Steinhart, 2006 |
Anti-parasitic | Metronidazole | inhibits nucleic acid synthesis | CD | 47% remission rate in patients | Prantera et al., 1996 |
Steroid | Methylprednisolone | Anti-inflammatory | CD | 68% remission of patients | Prantera et al., 1996 |
Steroid and antimicrobial combination | Clarithromycin Rifabutin, Clofazimine and 16-week course of corticosteroids | Antimicrobial Anti-inflammatory |
CD | Yes | Selby et al., 2007 |
Antimicrobial | Clarithromycin, Rifabutin, Ciprofloxacin, UVBI therapy and Clofazimine | Antimicrobial | CD | Yes | Kuenstner et al., 2015 |